PathGroup Selected as Early Access Partner for Launch of Illumina’s Sequencing-Based COVID-19 Diagnostic Test

NASHVILLE, Tenn.–(BUSINESS WIRE)–PathGroup has been selected as an early access partner for the launch of Illumina’s sequencing-based COVID-19 diagnostic test.